Amanote Research

Amanote Research

    RegisterSign In

Interleukin 1β—A Potential Salivary Biomarker for Cancer Progression?

Biomarkers in Cancer
doi 10.4137/bic.s25375
Full Text
Open PDF
Abstract

Available in full text

Date

January 1, 2015

Authors
Adi IdrisNur B. GhazaliDavid Koh
Publisher

SAGE Publications


Related search

Interleukin-6 Is a Potential Biomarker for Severe Pandemic H1N1 Influenza a Infection

PLoS ONE
Multidisciplinary
2012English

PIM-1 Kinase: A Potential Biomarker of Triple-Negative Breast Cancer

OncoTargets and Therapy
OncologyPharmacology
2019English

MALAT1: A Potential Biomarker in Cancer

Cancer Management and Research
Oncology
2018English

Salivary Interleukin 1-Beta Levels and Clinical Periodontal Parameters in Habitual Naswar Users and Non-Users

Pakistan Journal of Medical Sciences
Medicine
2019English

Interleukin-17: A Promoter in Colorectal Cancer Progression

Clinical and Developmental Immunology
2013English

Loss of Beclin 1 Expression in Ovarian Cancer: A Potential Biomarker for Predicting Unfavorable Outcomes

Oncology Letters
Cancer ResearchOncology
2017English

AKR1C3 Overexpression May Serve as a Promising Biomarker for Prostate Cancer Progression

Diagnostic Pathology
Forensic MedicineMedicinePathologyHistology
2014English

Interleukin-36α as a Potential Biomarker for Renal Tubular Damage Induced by Dietary Phosphate Load

FEBS Open Bio
BiochemistryGeneticsMolecular Biology
2020English

MiR-30a: A Novel Biomarker and Potential Therapeutic Target for Cancer

Journal of Oncology
Oncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy